Clinical trials
Active, not recruiting Phase 3 trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 10 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 11 |
| 2023 | 16 |
| 2024 | 24 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 10 |
| Hoffmann-La Roche | 8 |
| Novo Nordisk A/S | 8 |
| Amgen | 5 |
| AstraZeneca | 5 |
| Novartis Pharmaceuticals | 5 |
| Merck Sharp & Dohme LLC | 4 |
| argenx | 4 |
| Janssen Research & Development, LLC | 3 |
| Actelion | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 8 |
| Colitis, Ulcerative | 6 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Crohn Disease | 4 |
| Multiple Sclerosis, Relapsing-Remitting | 4 |
| Neoplasms | 4 |
| Arthritis, Psoriatic | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Multiple Sclerosis | 3 |
Trials
Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.